CES 2026: Withings Body Scan 2 tracks 60 biomarkers with a focus on longevity
Withings has unveiled Body Scan 2 at CES 2026, a smart health scale that promises clinical-grade insights from a 90-second full-body scan. The device collects over 60 biomarkers in one session, using a combination of bioimpedance spectroscopy, impedance cardiography and ECG to track cellular age, cardiovascular efficiency, arterial stiffness and more. All of this makes it the most feature-packed smart scale in existence.
A shift in focus toward proactive health-span
The company has positioned Body Scan 2 as a longevity station, not just a smart scale. The system is designed to catch early physiological imbalances caused by chronic stress, poor sleep, inactivity and diet. These silent disruptions, if left unchecked, can contribute to conditions like hypertension, diabetes or heart failure.
The scan uses five medical-grade sensing technologies to deliver a single view of how the body is functioning. Unlike most wearables, the platform focuses on longitudinal markers that evolve slowly over time, rather than chasing daily fluctuations.
Cardiac pumping performance is now included
This generation introduces impedance cardiography to measure how efficiently the heart pumps blood to the organs. Withings says low cardiac output is often a silent contributor to fatigue, poor stress response and reduced endurance. Early detection opens the door for users to adjust habits before larger problems take hold.
This is combined with a six-lead ECG for tracking heart rhythm and detecting atrial fibrillation. The system also calculates heart age and cardiac reactivity, giving users both a mechanical and electrical readout of heart performance in real-world conditions.
Blood pressure risk estimated without a cuff
The device also introduces a new hypertension risk notification. Using a clinically validated AI model, it estimates blood pressure trends based on each scan, without needing a separate cuff. This provides early warning for one of the most common but underdiagnosed health risks in adults.
Body Scan 2 also measures arterial stiffness using pulse wave velocity. From this, the system calculates vascular age and identifies zones where elasticity may be declining. According to Withings, this vascular data is both predictive and highly actionable.
Metabolism, inflammation and cellular age
Another major addition is ultra-high-frequency bioimpedance spectroscopy. This enables the scan to estimate cellular age, active cell mass and overall metabolic efficiency. It is designed to catch signs of metabolic slowdown or low-grade inflammation long before clinical tests would normally detect them.
All data is collected noninvasively, through the platform’s multi-point circuit created by standing on the scale and holding the retractable handle. This circuit spans the arms, torso and legs, enabling precise segmentation and full-body coverage.
Glycemic regulation without blood samples
The scale also introduces a new capability for detecting early glycemic imbalance. Withings says this is one of the first physiological systems to drift under poor lifestyle conditions. The system monitors electrical responses and sweat gland activity in the feet, using these to flag changes in glucose handling.
This insight is intended to give users time to intervene before prediabetes sets in. Like the rest of the scan, it does not require any blood sampling or additional accessories.
Trajectory-based model replaces standalone metrics
Rather than overwhelm users with data, Withings introduces a Health Trajectory score. This is based on personal baselines and is updated over time as more scans are taken. It reflects how the body is trending and what that might mean for long-term healthspan.
Other companies have similar metrics. For example Whoop, Garmin and a few smart ring makers. Granted, these are kind of arbitrary – and highly dependent on the brand. One device might tell you you are 5 years below your actual age, the other might tell you the opposite. It is not an exact science – at least not at the moment.
But this kind of modelling can be helpful to nudge you in the right direction as far as your lifestyle habits. It is particularly useful during transitional periods like perimenopause, midlife abdominal fat gain or GLP-1 treatment. It shows the effect of small adjustments over time rather than short-term fluctuations.
How it compares to the original Body Scan
Body Scan 2 builds on the same foundation as the original model, which I reviewed in detail back in 2023. That first-generation device was one of the few smart scales to offer segmental body composition analysis and six-lead ECG from a retractable handle. It also introduced vascular age and even tracked foot nerve health.
The new model keeps that form factor but deepens the physiological insight. Like before, the scale is built around a tempered-glass surface with eight embedded electrodes. The handle contains four additional sensors and a high-resolution LCD for viewing results. Two onboard buttons allow users to respond to prompts during the scan.
Battery life is rated for up to 15 months. The device syncs automatically to the app via Wi-Fi or Bluetooth. From a privacy standpoint, it meets GDPR and HIPAA requirements and carries ISO 27001 and 27701 certifications.
Body Scan 2 will launch in Q2 2026 at a price of 599.95 US dollars, 499.95 euros, 449.95 pounds and 899 Australian dollars. In the US, ECG and hypertension features will become available once FDA clearance is granted.
What is good to see is that Withings is trying to innovate. We look forward to seeing what else they have planned down the line.
Subscribe to our monthly newsletter! Check out our YouTube channel.
And of course, you can follow Gadgets & Wearables on Google News and add us as your preferred source to get our expert news, reviews, and opinion in your feeds.
